Loading...
Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients
Lung squamous cell carcinoma (LUSC) is a common type of lung cancer with high incidence and mortality rate. Tumor mutational burden (TMB) is an emerging biomarker for selecting patients with non-small cell lung cancer (NSCLC) for immunotherapy. This study aimed to reveal TMB involved in the mechanis...
Na minha lista:
| Udgivet i: | Sci Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8079676/ https://ncbi.nlm.nih.gov/pubmed/33907270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-88694-7 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|